Rockwell Medical (RMTI) Non-Current Deffered Revenue (2016 - 2024)
Historic Non-Current Deffered Revenue for Rockwell Medical (RMTI) over the last 9 years, with Q4 2024 value amounting to $429000.0.
- Rockwell Medical's Non-Current Deffered Revenue fell 968.42% to $429000.0 in Q4 2024 from the same period last year, while for Dec 2024 it was $429000.0, marking a year-over-year decrease of 968.42%. This contributed to the annual value of $429000.0 for FY2024, which is 968.42% down from last year.
- Per Rockwell Medical's latest filing, its Non-Current Deffered Revenue stood at $429000.0 for Q4 2024, which was down 968.42% from $441000.0 recorded in Q3 2024.
- Over the past 5 years, Rockwell Medical's Non-Current Deffered Revenue peaked at $9.5 million during Q1 2020, and registered a low of $429000.0 during Q4 2024.
- Its 5-year average for Non-Current Deffered Revenue is $4.4 million, with a median of $4.8 million in 2022.
- As far as peak fluctuations go, Rockwell Medical's Non-Current Deffered Revenue plummeted by 8933.19% in 2023, and later plummeted by 944.56% in 2024.
- Rockwell Medical's Non-Current Deffered Revenue (Quarter) stood at $8.0 million in 2020, then decreased by 25.32% to $6.0 million in 2021, then crashed by 56.57% to $2.6 million in 2022, then tumbled by 81.73% to $475000.0 in 2023, then decreased by 9.68% to $429000.0 in 2024.
- Its Non-Current Deffered Revenue stands at $429000.0 for Q4 2024, versus $441000.0 for Q3 2024 and $452000.0 for Q2 2024.